Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression

Oncology Reports

Volumn 22, Issue 3, 2009, Pages 563-567

  Sun, Qingmin ^a   Cong, Rihong ^a   Yan, Hongli ^b   Gu, Haijuan ^a   Zeng, Ying ^a   Liu, Nannan ^a   Chen, Jie ^a   Wang, Bin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Dongzhi Health Inspection Bureau   (China)

Author keywords

Genistein; MicroRNA 27a; Uveal melanoma; Zinc finger and BTB domain containing 10

Indexed keywords

GENE PRODUCT; GENISTEIN; MICRORNA; MICRORNA 27A; UNCLASSIFIED DRUG; ZINC FINGER AND BTB DOMAIN CONTAINING 10; ANTINEOPLASTIC AGENT; MIRN27 MICRORNA, HUMAN; ZINC FINGER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT; UVEA MELANOMA; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECT; DRUG SCREENING; FEMALE; GENETICS; MELANOMA; PATHOLOGY; TUMOR CELL LINE; UVEA TUMOR;

ANIMALS; ANTICARCINOGENIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENISTEIN; HUMANS; MELANOMA; MICE; MICE, INBRED BALB C; MICRORNAS; UVEAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS; ZINC FINGERS;

EID: 70349316774     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000472     Document Type: Article

References (34)

1. Singh AD and Topham A: Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology 110: 956-961, 2003.
2. Rajpal S, Moore R and Karakousis CP: Survival in metastatic ocular melanoma. Cancer 52: 334-336, 1983.
3. Diener-West M, Hawkins BS, Markowitz JA and Schachat AP: A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 110: 245-250, 1992.
4. Wöll E, Bedikian A and Legha SS: Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res 9: 575-581, 1999.
5. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
6. Hwang HW and Mendell JT: MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94: 776-780, 2006.
7. Chen CZ, Li L, Lodish HF and Bartel DP: MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86, 2004.
8. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, Ambros VR and Israel MA: Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67: 2456-2468, 2007.
9. Worley LA, Long MD, Onken MD and Harbour JW: Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Res 18: 184-190, 2008.
10. Dixon RA and Ferreira D: Genistein. Phytochemistry 60: 205-211, 2002.
11. Ullrich A and Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212, 1990.
12. Wang B, Zou Y, Li H, Yan H, Pan JS and Yuan ZL: Genistein inhibited retinal neovascularization and expression of vascular endothelial growth factor and hypoxia inducible factor 1alpha in a mouse model of oxygen-induced retinopathy. J Ocul Pharmacol Ther 21: 107-113, 2005.
13. Pan JS, Zhu HJ, Zhang B, Li H, Yan H and Wang B: Inhibitive effect of genistein on hypoxia-induced basic fibroblast growth factor expression in human retinal pigment epithelium cells. J Ocul Pharmacol Ther 22: 103-109, 2006.
14. Record IR, Broadbent JL, King RA, Dreosti IE, Head RJ and Tonkin AL: Genistein inhibits growth of B16 melanoma cells in vivo and in vitro and promotes differentiation in vitro. Int J Cancer 72: 860-864, 1997.
15. Tamura S, Bito T, Ichihashi M and Ueda M: Genistein enhances the cisplatin-induced inhibition of cell growth and apoptosis in human malignant melanoma cells. Pigment Cell Res 16: 470-476, 2003.
16. Liu T, Tang H, Lang Y, Liu M and Li X: MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 273: 233-242, 2008.
17. Mertens-Talcott SU, Chintharlapalli S, Li X and Safe S: The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 67: 11001-11011, 2007.
18. Seftor EA, Meltzer PS, Kirschmann DA, Pe'er J, Maniotis AJ, Trent JM, Folberg R and Hendrix MJ: Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis 19: 233-246, 2002.
19. Farina HG, Pomies M, Alonso DF and Gomez DE: Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Rep 16: 885-891, 2006.
20. Zhou JR, Yu L, Mai Z and Blackburn GL: Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int J Cancer 108: 8-14, 2004.
21. Shao ZM, Wu J, Shen ZZ and Barsky SH: Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 58: 4851-4587, 1998.
22. Lakshman M, Xu L, Ananthanarayanan V, Cooper J, Takimoto CH, Helenowski I, Pelling JC and Bergan RC: Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Res 68: 2024-2032, 2008.
23. Banerjee S, Li Y, Wang Z and Sarkar FH: Multi-targeted therapy of cancer by genistein. Cancer Lett 269: 226-242, 2008.
24. Wang B, Zou Y, Yuan ZL and Xiao JG: Genistein suppressed upregulation of vascular endothelial growth factor expression by cobalt chloride and hypoxia in rabbit retinal pigment epithelium cells. J Ocul Pharmacol Ther 19: 457-464, 2003.
25. Russo A, Cardile V, Lombardo L, Vanella L and Acquaviva R: Genistin inhibits UV light-induced plasmid DNA damage and cell growth in human melanoma cells. J Nutr Biochem 17: 103-108, 2006.
26. Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, Deguchi T and Ito M: Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun 377: 114-119, 2008.
27. Gal H, Pandi G, Kanner AA, Ram Z, Lithwick-Yanai G, Amariglio N, Rechavi G and Givol D: MIR-451 and Imatinib mesylate inhibit tumor growth of glioblastoma stem cells. Biochem Biophys Res Commun 376: 86-90, 2008.
28. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, Hong L, Liu J and Fan D: miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123: 372-379, 2008.
29. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C and Zheng ZM: Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE 3: e2557, 2008.
30. Scott GK, Mattie MD, Berger CE, Benz SC and Benz CC: Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 66: 1277-1281 2006.
31. Wang L, Wei D, Huang S, Peng Z, Le X, Wu TT, Yao J, Ajani J and Xie K: Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 9: 6371-6380, 2003.
32. Zannetti A, Del Vecchio S, Carriero MV, Fonti R, Franco P, Botti G, D'Aiuto G, Stoppelli MP and Salvatore M: Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. Cancer Res 60: 1546-1551, 2000.
33. Hosoi Y, Watanabe T, Nakagawa K, Matsumoto Y, Enomoto A, Morita A, Nagawa H and Suzuki N: Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol 25: 461-468, 2004.
34. Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu CG and Yang JM: Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 76: 582-588, 2008.